Skip to main content

POTENCIACION DEL PODER DE QUEMAR GRASAS DEL TEJIDO ADIPOSO MARRON COMO TERAPIA CONTRA LA OBESIDAD Y LA DIABETES

SAF2013-45887-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • Gonzalez-Franquesa, Alba
  • Gama Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon
  • Monsalve, Maria
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Carracedo, Angel
  • Perales , José Carlos
  • Nogueiras, Ruben
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes

  • Valdecantos, M. P.
  • Pardo, Virginia
  • Santamaria, Beatriz
  • Muntané, Jordi
  • Cuadrado, Antonio
  • Valverde, Ángela M.
et al., Excess of saturated free fatty acids, such as palmitic acid (PA), in hepatocytes has been implicated in nonalcoholic fatty liver disease. α-Lipoic acid (LA) is an antioxidant that protects against oxidative stress conditions. We have investigated the effects of LA in the early activation of oxidative and endoplasmic reticulum stress, lipid accumulation, and Nrf2-mediated antioxidant defenses in hepatocytes treated with PA or in rats fed a high-fat diet. In primary human hepatocytes, a lipotoxic concentration of PA triggered endoplasmic reticulum stress, induced the apoptotic transcription factor CHOP, and increased the percentage of apoptotic cells. Cotreatment with LA prevented these effects. Similar results were found in mouse hepatocytes in which LA attenuated PA-mediated activation of caspase 3 and reduced lipid accumulation by decreasing PA uptake and increasing fatty acid oxidation and lipophagy, thereby preventing lipoapoptosis. Moreover, LA augmented the proliferation capacity of hepatocytes after PA challenge. Antioxidant effects of LA ameliorated reactive oxygen species production and endoplasmic reticulum stress and protected against mitochondrial apoptosis in hepatocytes treated with PA. Cotreatment with PA and LA induced an early nuclear translocation of Nrf2 and activated antioxidant enzymes, whereas reduction of Nrf2 by siRNA abolished the benefit of LA on PA-induced lipoapoptosis. Importantly, posttreatment with LA reversed the established damage induced by PA in hepatocytes, as well as preventing obesity-induced oxidative stress and lipoapoptosis in rat liver. In conclusion, our work has revealed that in hepatocytes, Nrf2 is an essential early player in the rescue of oxidative stress by LA leading to protection against PA-mediated lipoapoptosis., We acknowledge the following grant support: SAF2012-33283 (Ministry of Economy and Competitiveness, MINECO, Spain), Comunidad de Madrid S2010/BMD-2423, EFSD and Amylin Paul Langerhans Grant, and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (ISCIII, Spain) to A.M.V.; SAF2010-17822 (MINECO, Spain) and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (ISCIII, Spain) to A.C.; PI09/0185 (ISCIII, Spain) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ISCIII, Spain) to J.M.; Línea especial “Nutrición, Obesidad y Salud” (University of Navarra LE/97) and AGL2006-04716/ALI and AGL2009-10873/ALI (Ministry of Science and Innovation, Spain) and Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (ISCIII, Spain) to D.S., J.A.M., and M.J.M.; SAF2013-45887-R to L.H. and SAF2011-30520-C02-01 to D.S. (MINECO, Spain), Generalitat de Catalunya (2014SGR-465 to D.S.); and EFSD/Lilly and EFSD/Janssen and L’Oréal-UNESCO research fellowships to L.H. M.W. is the recipient of a Ciência sem Fronteiras–CNPq fellowship (237976/2012-9). M.P.V. holds a scholarship from Instituto de Salud Carlos III (ISCIII, Ministry of Health, Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes

  • García-Casarrubios, Ester
  • Arroba, Ana I.
  • Pescador, Nuria
  • García, Laura
  • Cadenas, Susana
  • Carvalho, Eugenia
  • Obregón, María Jesús
  • Valverde, Ángela M.
New onset diabetes after transplantation (NODAT) is a metabolic disorder that affects 40% of patients on immunosuppressive agent (IA) treatment, such as rapamycin (also known as sirolimus). IAs negatively modulate insulin action in peripheral tissues including skeletal muscle, liver and white fat. However, the effects of IAs on insulin sensitivity and thermogenesis in brown adipose tissue (BAT) have not been investigated. We have analyzed the impact of rapamycin on insulin signaling, thermogenic gene-expression and mitochondrial respiration in BAT. Treatment of brown adipocytes with rapamycin for 16 h significantly decreased insulin receptor substrate 1 (IRS1) protein expression and insulin-mediated protein kinase B (Akt) phosphorylation. Consequently, both insulin-induced glucose transporter 4 (GLUT4) translocation to the plasma membrane and glucose uptake were decreased. Early activation of the N-terminal Janus activated kinase (JNK) was also observed, thereby increasing IRS1 Ser 307 phosphorylation. These effects of rapamycin on insulin signaling in brown adipocytes were partly prevented by a JNK inhibitor. In vivo treatment of rats with rapamycin for three weeks abolished insulin-mediated Akt phosphorylation in BAT. Rapamycin also inhibited norepinephrine (NE)-induced lipolysis, the expression of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and uncoupling protein (UCP)-1 in brown adipocytes. Importantly, basal mitochondrial respiration, proton leak and maximal respiratory capacity were significantly decreased in brown adipocytes treated with rapamycin. In conclusion, we demonstrate, for the first time the important role of brown adipocytes as target cells of rapamycin, suggesting that insulin resistance in BAT might play a major role in NODAT development., This work was supported by Ministerio de Economía y Competitividad: (SAF2015-65267-R to AMV, SAF2012-32491 to MJO, SAF2013-45887-R to LH, and SAF2014-52223-C2-1-R to DS) that were cofunded by the Fondos Europeos de Desarrollo Regional de la Unión Europea [FEDER], Spain, Instituto de Salud Carlos III (FIS PI15-00448 to SC and INFLAMES PIE14/00045 to AMV), Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem, ISCIII, Spain) to AMV, Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBERobn-Grant CB06/03/0001) to DS and S2010/BMD-2423 (Comunidad de Madrid, Spain) to AMV and MJO and S2010/BMD-2402 to SC and 2014SGR465 (Generalitat de Catalunya, Spain) to DS. CdM was supported by the Albert Reynold Grant travel fellowship from the European Foundation for the Study of Diabetes. EC and FR were funded by FEDER through the Operational Programme Competitiveness Factors - COMPETE and by FCT - Foundation for Science and TechnologyPTDC/SAU-OSM/104124/2008 and strategic project UID/NEU/04539/2013., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Carnitine palmitoyltransferase 1 increases lipolysis, UCP1 protein expression and mitochondrial activity in brown adipocytes

  • Calderón‐Domínguez, María
  • García-Casarrubios, Ester
  • Obregón, María Jesús
  • Valverde, Ángela M.
  • Herrero, Laura
This is an open access article distributed under the terms of the Creative Commons Attribution License.-- et al., The discovery of active brown adipose tissue (BAT) in adult humans and the fact that it is reduced in obese and diabetic patients have put a spotlight on this tissue as a key player in obesity-induced metabolic disorders. BAT regulates energy expenditure through thermogenesis; therefore, harnessing its thermogenic fat-burning power is an attractive therapeutic approach. We aimed to enhance BAT thermogenesis by increasing its fatty acid oxidation (FAO) rate. Thus, we expressed carnitine palmitoyltransferase 1AM (CPT1AM), a permanently active mutant form of CPT1A (the rate-limiting enzyme in FAO), in a rat brown adipocyte (rBA) cell line through adenoviral infection. We found that CPT1AM-expressing rBA have increased FAO, lipolysis, UCP1 protein levels and mitochondrial activity. Additionally, enhanced FAO reduced the palmitate-induced increase in triglyceride content and the expression of obese and inflammatory markers. Thus, CPT1AM-expressing rBA had enhanced fat-burning capacity and improved lipid-induced derangements. This indicates that CPT1AM-mediated increase in brown adipocytes FAO may be a new approach to the treatment of obesity-induced disorders., This work was supported by the Ministry of Spain - MINECO (SAF2013-45887-R to LH, SAF2014-52223-C2-1-R to DS and SAF-2015-65267-R to AMV that were cofunded by the Fondos Europeos de Desarrollo Regional de la Unión Europea [FEDER], SAF2012-32491 to MJO, SAF2013-40987R to AZ, and a doctoral fellowship to JFM), the Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (Grant CB06/03/0001 to DS), the Centro de Investigación Biomédica en red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), the Generalitat de Catalunya (2014SGR465 to DS, and 2014SGR48 to AZ), the Comunidad de Madrid (S2010/BMD-2423 to MJO and AMV), INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178) to AZ, and the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L’Oréal-UNESCO “For Women in Science” research fellowships to LH. AZ is a recipient of ICREA-Academia (Generalitat de Catalunya) and MW is a recipient of the Ciência sem Fronteiras-CNPq fellowship (237976/2012-9)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation

  • Calderón‐Domínguez, María
  • Escoté, Xavier
  • Gómez-Serrano, María
  • Peral, Belén
  • Fernández-Veledo, Sonia
  • Vázquez-Carrera, Manuel
  • Villaroya, Francesc
  • Vendrell, Joan
  • Herrero, Laura
Lipid overload in obesity and type 2 diabetes is associated with adipocyte dysfunction, inflammation, macrophage infiltration, and decreased fatty acid oxidation (FAO). Here, we report that the expression of carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme in mitochondrial FAO, is higher in human adipose tissue macrophages than in adipocytes and that it is differentially expressed in visceral vs. subcutaneous adipose tissue in both an obese and a type 2 diabetes cohort. These observations led us to further investigate the potential role of CPT1A in adipocytes and macrophages. We expressed CPT1AM, a permanently active mutant form of CPT1A, in 3T3-L1 CAR¿1 adipocytes and RAW 264.7 macrophages through adenoviral infection. Enhanced FAO in palmitate-incubated adipocytes and macrophages reduced triglyceride content and inflammation, improved insulin sensitivity in adipocytes, and reduced endoplasmic reticulum stress and ROS damage in macrophages. We conclude that increasing FAO in adipocytes and macrophages improves palmitate-induced derangements. This indicates that enhancing FAO in metabolically relevant cells such as adipocytes and macrophages may be a promising strategy for the treatment of chronic inflammatory pathologies such as obesity and type 2 diabetes., This study was supported by the Spanish Ministry of Science and Innovation (Grants SAF2010-20039 and SAF2013-45887-R to L. Herrero, SAF2011-30520-C02-01 to D. Serra, PI11/00085 to J. J. Vendrell, SAF2012-33014 to B. Peral, SAF2012-36186 to S. Fernández-Veledo, SAF2012-30708 to M. Vázquez-Carrera, SAF2011-23626 to F. Villarroya, and doctoral fellowships to M. I. Malandrino and J. F. Mir), by the CIBER Fisiopatología de la Obesidad y la Nutrición (Grant CB06/03/0001 to D. Serra), and CIBER Diabetes y Enfermedades Metabólicas Asociadas (Grant CB07/08/0003 to M. Vázquez-Carrera), Instituto de Salud Carlos III, by the European Union (BetaBat project FP7-277713 to F. Villarroya), by the European Foundation for the Study of Diabetes (EFSD)/Lilly and EFSD/Janssen-Rising Star research fellowships to L. Herrero, and by a L’Oréal-UNESCO “For Women in Science” research fellowship to L. Herrero. S. Fernández-Veledo acknowledges support from the “Miguel Servet” tenure track program (CP10/00438) from the Fondo de Investigación Sanitaria and cofinanced by the European Regional Development Fund. M. Weber is a recipient of the Ciência sem Fronteiras-CNPq fellowship (237976/2012-9)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ceramides and mitochondrial fatty acid oxidation in obesity

  • Fucho, Raquel
  • Casals, Núria
  • Serra, Dolors
  • Herrero, Laura
Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes to lipid accumulation within the cells, conferringmore susceptibility to cell dysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity-derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity., This work was supported by the Ministry of Spain (MINECO) Grants SAF2013-45887-R (to L.H.), SAF2014-52223-C2-1-R (to D.S.), and SAF2014-52223-C2-2-R (to N.C.), and cofunded by the Fondos Europeos de Desarrollo Regional (FEDER); and by Centro de Investigacion Biom ´ edica en Red de Fisiopatolog ´ ´ıa de la Obesidad y la Nutricion (CIBEROBN) Grant CB06/03/0001 ´ (to D.S.); Government of Catalonia Grant 2014SGR465 (to D.S.); Marato TV3 Foundation (to D.S., N.C.); and the ´ European Foundation for the Study of Diabetes (EFSD)/ Janssen-Rising Star and L’Or´eal-UNESCO “For Women in Science” research fellowships (to L.H.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ghrelin causes a decline in GABA release by reducing fatty acid oxidation in cortex

  • Mir, Joan Francesc
  • Zagmutt, Sebastián
  • Lichtenstein, Mathieu
  • García-Villoria, Judit
  • Weber, Minéia
  • Gracia, Ana
  • Fabriàs, Gemma
  • Casas, Josefina
  • López, Miguel
  • Casals, Núria
  • Ribes, Antònia
  • Suñol, Cristina
  • Herrero, Laura
  • Serra, Dolors
Lipid metabolism, specifically fatty acid oxidation (FAO) mediated by carnitine palmitoyltransferase (CPT) 1A, has been described to be an important actor of ghrelin action in hypothalamus. However, it is not known whether CPT1A and FAO mediate the effect of ghrelin on the cortex. Here, we show that ghrelin produces a differential effect on CPT1 activity and γ-aminobutyric acid (GABA) metabolism in the hypothalamus and cortex of mice. In the hypothalamus, ghrelin enhances CPT1A activity while GABA transaminase (GABAT) activity, a key enzyme in GABA shunt metabolism, is unaltered. However, in cortex CPT1A activity and GABAT activity are reduced after ghrelin treatment. Furthermore, in primary cortical neurons, ghrelin reduces GABA release through a CPT1A reduction. By using CPT1A floxed mice, we have observed that genetic ablation of CPT1A recapitulates the effect of ghrelin on GABA release in cortical neurons, inducing reductions in mitochondrial oxygen consumption, cell content of citrate and α-ketoglutarate, and GABA shunt enzyme activity. Taken together, these observations indicate that ghrelin-induced changes in CPT1A activity modulate mitochondrial function, yielding changes in GABA metabolism. This evidence suggests that the action of ghrelin on GABA release is region specific within the brain, providing a basis for differential effects of ghrelin in the central nervous system., This work was supported by the Ministry of Spain (MINECO) (SAF2015-71026-R and BFU2015-70454-REDT/ Adipoplast to ML, SAF2013-45887-R to LH, SAF2014-52223-C2-1-R to DS, and SAF2014-52223-C2-2-R to NC, cofunded by the European Regional Development Fund [ERDF]), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (Grant CB06/03/0001 to DS), the Government of Catalonia (2014SGR465 to DS), the Fundació La Marató de TV3 (201627-30 to DS), the Xunta de Galicia (2015-CP079 to ML) and the European Community’s Seventh Framework Programme (FP7/2007- 2013) under grant agreement no. 281854 – the ObERStress project to ML., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, Alba
  • Gama-Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Durán, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramón
  • Monsalve, María
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Perales, José Carlos
  • Nogueiras, Rubén
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Óscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., This work has been supported by Ministerio de Ciencia e Innovacion ´ (MICINN) Grant BFU2011- 24679 (P.M.G.-R.); Instituto de Salud Carlos III (ISCIII) Grant PI15/00701 (P.M.G.-R.) cofinanced by the European Regional Development Fund ‘‘A way to build Europe’‘; Government of Catalonia Support Grups de Recerca AGAUR 2017-SGR-204 (to J.C.P. and P.M.G-R.), 2017-SGR-736 (to J.I.M.-S.) and 2017-SGR-896 (to A.A.- M., M.S.-P., and R.G.). M.M. was recipient of a MINECO grant RTI2018- 093864-B-I00. O.Y. was funded by MINECO grant BFU2017-87958. M. A.K. was funded by a Medical University of Innsbruck Start Grant. M.C. was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement 725004). L. H. was funded by MINECO grants SAF2013- 45887-R, SAF2017-83813-C3-1-R (granted to Dolors Serra (DS) and L. H.), co-funded by the European Regional Development Fund, the Centro de Investigacion ´ Biom´edica en Red de Fisiopatología de la Obesidad y la Nutricion ´ (CIBEROBN) (Grant CB06/03/0001 to DS), the Government of Catalonia (2017SGR278 to DS), the Fundacio ´ La Marato ´ de TV3 (201627–30 to DS), the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L’Or´eal-UNESCO “For Women in Science” research fellowships. P.M.G.-R. was a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. A.G-F. was a recipient of “Beca de Formacio ´ de Personal Investigador de l’IDIBAPS” fellowship and she is currently supported by an unconditional donation from the Novo Nordisk Foundation (NNF) to NNF Center for Basic Metabolic Research (NNF18CC0034900). P.G-P. was a recipient of predoctoral fellowship from the Universitat de Barcelona (APIF-UB). K.S was financed through “Advanced Postdoc Grant” from SFB 1218 (DFG, German Reuter Foundation, Projektnummer 269925409). J.M-B. was a recipient of predoctoral fellowship from the European Union’s Horizon 2020 research and innovation program under the Marie SkłodowskaCurie grant agreement 675610. E.S-R. was recipient of a predoctoral fellowship from Ministerio de Economia y Empresa (MINECO) grant BES-2013-062796. This work was partially developed at the Esther Koplowitz Center (CEK, Barcelona, Spain).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, A.
  • Gama-Pérez, P.
  • Kulis, M.
  • Szczepanowska, K.
  • Dahdah, N.
  • Moreno-Gómez, S.
  • Latorre Pellicer, A.
  • Fernández-Ruiz, R.
  • Aguilar-Mogas, A.
  • Hoffman, A.
  • Monelli, E.
  • Samino, S.
  • Miró-Blanch, J.
  • Oemer, G.
  • Duran, X.
  • Sánchez-Rebordelo, E.
  • Schneeberger, M.
  • Obach, M.
  • Montane, J.
  • Castellano, G.
  • Chapaprieta, V.
  • Sun, W.
  • Navarro, L.
  • Prieto, I.
  • Castaño, C.
  • Novials, A.
  • Gomis, R.
  • Monsalve, M.
  • Claret, M.
  • Graupera, M.
  • Soria, G.
  • Wolfrum, C.
  • Vendrell, J.
  • Fernández-Veledo, S.
  • Enríquez, J. A.
  • Carracedo, A.
  • Perales, J. C.
  • Nogueiras, R.
  • Herrero, L.
  • Trifunovic, A.
  • Keller, M. A.
  • Yanes, O.
  • Sales-Pardo, M.
  • Guimerà, R.
  • Blüher, M.
  • Martín-Subero, J. I.
  • García-Roves, P.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • Gonzalez-Franquesa, Alba
  • Gama Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon
  • Monsalve, Maria
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Carracedo, Angel
  • Perales , José Carlos
  • Nogueiras, Ruben
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Increased infammation, oxidative stress and mitochondrial respiration in brown adipose tissue from obese mice

  • Alcalá, Martín
  • Calderón-Domínguez, María
  • Bustos, Eduviges
  • Ramos, Pilar
  • Casals i Farré, Núria
  • Serra, Dolors
  • Viana, Marta
  • Herrero Rodríguez, Laura
Tis work was supported by the Ministry of Spain (MINECO) (SAF2013-45887-R to LH, SAF2014-56671R to PR, SAF2014-52223-C2-1-R to DS, and SAF2014-52223-C2-2-R to NC, cofunded by the European Regional Development Fund [ERDF]), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (Grant CB06/03/0001 to DS), the Government of Catalonia (2014SGR465 to DS), and the Fundació La Marató de TV3 to DS. We acknowledge A. Zorzano and D. Sebastián (IRB, Barcelona, Spain) for assistance with the Seahorse., Obesity is associated with severe metabolic diseases such as type 2 diabetes, insulin resistance, cardiovascular disease and some forms of cancer. The pathophysiology of obesity-induced metabolic diseases has been strongly related to white adipose tissue (WAT) dysfunction through several mechanisms such as fibrosis, apoptosis, inflammation, ER and oxidative stress. However, little is known of whether these processes are also present in brown adipose tissue (BAT) during obesity, and the potential consequences on mitochondrial activity. Here we characterized the BAT of obese and hyperglycemic mice treated with a high-fat diet (HFD) for 20 weeks. The hypertrophic BAT from obese mice showed no signs of fibrosis nor apoptosis, but higher levels of inflammation, ER stress, ROS generation and antioxidant enzyme activity than the lean counterparts. The response was attenuated compared with obesity-induced WAT derangements, which suggests that BAT is more resistant to the obesity-induced insult. In fact, mitochondrial respiration in BAT from obese mice was enhanced, with a 2-fold increase in basal oxygen consumption, through the upregulation of complex III of the electron transport chain and UCP1. Altogether, our results show that obesity is accompanied by an increase in BAT mitochondrial activity, inflammation and oxidative damage., info:eu-repo/semantics/acceptedVersion